30,601 Shares in Colgate-Palmolive (NYSE:CL) Bought by SVB Wealth LLC

SVB Wealth LLC purchased a new position in Colgate-Palmolive (NYSE:CL - Free Report) during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund purchased 30,601 shares of the company's stock, valued at approximately $2,782,000.

A number of other hedge funds and other institutional investors also recently made changes to their positions in the stock. Flputnam Investment Management Co. boosted its holdings in Colgate-Palmolive by 1.8% in the fourth quarter. Flputnam Investment Management Co. now owns 168,367 shares of the company's stock valued at $15,306,000 after acquiring an additional 3,047 shares in the last quarter. Parkside Financial Bank & Trust grew its stake in shares of Colgate-Palmolive by 3.0% during the 4th quarter. Parkside Financial Bank & Trust now owns 6,673 shares of the company's stock valued at $607,000 after purchasing an additional 194 shares during the period. QRG Capital Management Inc. grew its stake in shares of Colgate-Palmolive by 2.3% during the 4th quarter. QRG Capital Management Inc. now owns 65,836 shares of the company's stock valued at $5,985,000 after purchasing an additional 1,494 shares during the period. First Command Advisory Services Inc. grew its stake in shares of Colgate-Palmolive by 8.6% during the 4th quarter. First Command Advisory Services Inc. now owns 6,489 shares of the company's stock valued at $590,000 after acquiring an additional 514 shares during the period. Finally, Proficio Capital Partners LLC bought a new position in Colgate-Palmolive in the 4th quarter worth approximately $186,000. 80.41% of the stock is owned by hedge funds and other institutional investors.

Colgate-Palmolive Stock Performance

CL traded up $0.81 on Wednesday, reaching $91.87. The company had a trading volume of 3,446,465 shares, compared to its average volume of 4,102,627. Colgate-Palmolive has a fifty-two week low of $85.32 and a fifty-two week high of $109.30. The stock has a market cap of $74.56 billion, a P/E ratio of 26.10, a P/E/G ratio of 4.20 and a beta of 0.44. The company's fifty day moving average is $88.72 and its 200 day moving average is $95.27. The company has a debt-to-equity ratio of 13.40, a quick ratio of 0.58 and a current ratio of 0.92.

Colgate-Palmolive (NYSE:CL - Get Free Report) last issued its quarterly earnings data on Friday, January 31st. The company reported $0.91 EPS for the quarter, beating the consensus estimate of $0.90 by $0.01. Colgate-Palmolive had a net margin of 14.38% and a return on equity of 477.77%. During the same period in the prior year, the business posted $0.87 earnings per share. As a group, analysts predict that Colgate-Palmolive will post 3.75 earnings per share for the current fiscal year.

Colgate-Palmolive Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Friday, February 14th. Investors of record on Tuesday, January 21st were given a dividend of $0.50 per share. This represents a $2.00 dividend on an annualized basis and a dividend yield of 2.18%. The ex-dividend date of this dividend was Tuesday, January 21st. Colgate-Palmolive's payout ratio is currently 56.82%.

Analysts Set New Price Targets

Several analysts recently weighed in on the company. Raymond James restated an "outperform" rating and set a $105.00 price target (down previously from $110.00) on shares of Colgate-Palmolive in a report on Monday, February 3rd. Morgan Stanley decreased their price target on Colgate-Palmolive from $111.00 to $104.00 and set an "overweight" rating for the company in a research note on Monday, February 3rd. UBS Group reduced their price target on Colgate-Palmolive from $104.00 to $100.00 and set a "buy" rating for the company in a research report on Monday, February 3rd. TD Cowen dropped their price objective on Colgate-Palmolive from $110.00 to $100.00 and set a "buy" rating on the stock in a report on Wednesday, January 8th. Finally, JPMorgan Chase & Co. reduced their price objective on Colgate-Palmolive from $103.00 to $97.00 and set an "overweight" rating on the stock in a research report on Monday, February 3rd. One equities research analyst has rated the stock with a sell rating, nine have issued a hold rating and twelve have assigned a buy rating to the stock. Based on data from MarketBeat, the company currently has a consensus rating of "Moderate Buy" and an average price target of $101.61.

Colgate-Palmolive Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.